This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cui, Y.
Right arrow Articles by Chang, L.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cui, Y.
Right arrow Articles by Chang, L.-J.

 Previous Article  |  Next Article 

Journal of Virology, July 1999, p. 6171-6176, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Contributions of Viral Splice Sites and cis-Regulatory Elements to Lentivirus Vector Function

Yan Cui, Tomoo Iwakuma, and Lung-Ji Chang*

Department of Molecular Genetics and Microbiology, Gene Therapy Center, and University of Florida Brain Institute, College of Medicine, University of Florida, Gainesville, Florida 32610-0266

Received 28 October 1998/Accepted 9 April 1999

The mobile transgene constructs of most human immunodeficiency virus (HIV)-based lentivirus vectors currently in use contain viral long terminal repeats, a 5' untranslated region, gag sequences, and env sequences that include the Rev-responsive element (RRE). In this study, we examined the possibility of deleting HIV splice sites and gag and env sequences from an HIV type 1 recombinant vector established in our laboratory as part of our ongoing efforts to improve this vector system. Mutations in the major splice donor site (SD) markedly reduced viral RNA expression but had little effect on vector titer. Deletion of gag or env sequences, excluding RRE, led to a moderate reduction in vector titer. Interestingly, deletion of RRE slightly reduced viral RNA expression but markedly impaired vector function. Combined deletions of RRE, gag (except for the first 40 nucleotides), env, and the SD mutation resulted in a twofold increase in cytoplasmic viral RNA expression and a recovery of vector efficiency to ~50% of the wild-type level. This increase in cytoplasmic RNA levels is likely to be due, at least in part, to effects of the TE671 host cells, a human rhabdomyosarcoma cell line used for vector production in our system, on the cytoplasmic distribution of spliced and unspliced viral RNA. These results show that optimal lentivirus vector function can be maintained in the absence of multiple essential viral elements.

* Corresponding author. Mailing address: Rm. R1-252, ARB, Department of Molecular Genetics and Microbiology, Gene Therapy Center, University of Florida, Gainesville, FL 32610-0266. Phone: (352) 392-3315. Fax: (352) 392-3133. E-mail: lchang{at}college.med.ufl.edu.

Journal of Virology, July 1999, p. 6171-6176, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Chan, Y.-L., Chang, T.-H., Liao, C.-L., Lin, Y.-L. (2008). The Cellular Antiviral Protein Viperin Is Attenuated by Proteasome-Mediated Protein Degradation in Japanese Encephalitis Virus-Infected Cells. J. Virol. 82: 10455-10464 [Abstract] [Full Text]  
  • Yu, C.-Y., Hsu, Y.-W., Liao, C.-L., Lin, Y.-L. (2006). Flavivirus Infection Activates the XBP1 Pathway of the Unfolded Protein Response To Cope with Endoplasmic Reticulum Stress. J. Virol. 80: 11868-11880 [Abstract] [Full Text]  
  • Bona, R., Andreotti, M., Buffa, V., Leone, P., Galluzzo, C. M., Amici, R., Palmisano, L., Mancini, M. G., Michelini, Z., Di Santo, R., Costi, R., Roux, A., Pommier, Y., Marchand, C., Vella, S., Cara, A. (2006). Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds.. Antimicrob. Agents Chemother. 50: 3407-3417 [Abstract] [Full Text]  
  • Song, M., Balakrishnan, M., Chen, Y., Roques, B. P., Bambara, R. A. (2006). Stimulation of HIV-1 Minus Strand Strong Stop DNA Transfer by Genomic Sequences 3' of the Primer Binding Site. J. Biol. Chem. 281: 24227-24235 [Abstract] [Full Text]  
  • Buffa, V., Negri, D. R. M., Leone, P., Bona, R., Borghi, M., Bacigalupo, I., Carlei, D., Sgadari, C., Ensoli, B., Cara, A. (2006). A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)HXB2 Rev/Env or codon-optimized HIV-1JR-FL gp120 generates durable immune responses in mice. J. Gen. Virol. 87: 1625-1634 [Abstract] [Full Text]  
  • Lin, R.-J., Chang, B.-L., Yu, H.-P., Liao, C.-L., Lin, Y.-L. (2006). Blocking of Interferon-Induced Jak-Stat Signaling by Japanese Encephalitis Virus NS5 through a Protein Tyrosine Phosphatase-Mediated Mechanism.. J. Virol. 80: 5908-5918 [Abstract] [Full Text]  
  • Weinberger, L. S., Schaffer, D. V., Arkin, A. P. (2003). Theoretical Design of a Gene Therapy To Prevent AIDS but Not Human Immunodeficiency Virus Type 1 Infection. J. Virol. 77: 10028-10036 [Abstract] [Full Text]  
  • Coleman, J. E., Huentelman, M. J., Kasparov, S., Metcalfe, B. L., Paton, J. F. R., Katovich, M. J., Semple-Rowland, S. L., Raizada, M. K. (2003). Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo. Physiol. Genomics 12: 221-228 [Abstract] [Full Text]  
  • Zaiss, A.-K., Son, S., Chang, L.-J. (2002). RNA 3' Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and Efficacy. J. Virol. 76: 7209-7219 [Abstract] [Full Text]  
  • Cui, Y., Golob, J., Kelleher, E., Ye, Z., Pardoll, D., Cheng, L. (2002). Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood 99: 399-408 [Abstract] [Full Text]  
  • D’Costa, J., Brown, H. M., Kundra, P., Davis-Warren, A., Arya, S. K. (2001). Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation. J. Gen. Virol. 82: 425-434 [Abstract] [Full Text]  
  • Graf, M., Bojak, A., Deml, L., Bieler, K., Wolf, H., Wagner, R. (2000). Concerted Action of Multiple cis-Acting Sequences Is Required for Rev Dependence of Late Human Immunodeficiency Virus Type 1 Gene Expression. J. Virol. 74: 10822-10826 [Abstract] [Full Text]  
  • Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M., Mitrophanous, K. A. (2000). A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1 gag-pol Gene. J. Virol. 74: 4839-4852 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»